Absolute neutrophil count greater than 1000/mm^3 without support of filgrastim
Absolute neutrophil count greater than 1000/mm^3 without the support of filgrastim
Absolute neutrophil count greater than 1000/mm^3 without the support of filgrastim
Absolute neutrophil count greater than 1000/mm^3 without support of filgrastim
Absolute neutrophil count > 1000/mm^3 without the support of filgrastim
Absolute neutrophil count greater than 1000/mm^3 without support of filgrastim
Absolute neutrophil count > 1000/mm^3 without the support of filgrastim
Absolute neutrophil count greater than 1000/mm^3 without the support of filgrastim
Absolute neutrophil count greater than 1500/mm^3 without the support of filgrastim
Absolute neutrophil count greater than or equal to 1000/mm^3 without the support of filgrastim or other growth factors
Absolute neutrophil count greater than 1000/mm^3 without the support of filgrastim
Absolute neutrophil count greater than 1000/mm^3 without the support of filgrastim
Absolute neutrophil count greater than 1000/mm^3 without the support of filgrastim
Absolute neutrophil count (ANC) >= 1000/mm^3 without the support of filgrastim
Absolute neutrophil count greater than or equal to 1000/mm^3 without the support of filgrastim or other growth factors
Absolute neutrophil count greater than 1000/mm^3 without the support of filgrastim
Absolute neutrophil count greater than 1000/mm^3 without the support of filgrastim
Absolute neutrophil count greater than 1000/mm^3 without the support of filgrastim
Absolute neutrophil count greater than 1000/mm^3 without the support of filgrastim
Absolute neutrophil count (ANC) >= 1 K/mcL, with or without filgrastim (GCSF) support
Absolute neutrophil count (ANC) >= 1000/mm^3 without the support of filgrastim
Absolute neutrophil count greater than 1000/mm3 without the support of filgrastim
Absolute neutrophil count greater than or equal to 1000/mm^3 without the support of filgrastim or other growth factors
Absolute neutrophil count greater than 1500/mm^3 without the support of filgrastim
Absolute neutrophil count greater than 1000/mm^3 without the support of filgrastim
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L without filgrastim (GCSF) support within 7 days
Absolute neutrophil count greater than 1000/mm^3 without the support of filgrastim
Absolute neutrophil count greater than or equal to 1000/mm^3 without the support of filgrastim
Absolute neutrophil count greater than 1000/mm^3 without the support of filgrastim
Absolute neutrophil count greater than 1000/mm^3 without the support of filgrastim
Absolute neutrophil count greater than 1000/mm^3 without the support of filgrastim
Absolute neutrophil count greater than 1000/mm^3 without the support of filgrastim
Absolute neutrophil count greater than 1000/mm^3 without the support of filgrastim
Absolute neutrophil count greater than 1000/mm^3 without the support of filgrastim
Absolute neutrophil count greater than 1000/mm^3 without the support of filgrastim
Hematopoietic engraftment as evidenced by recovery of the absolute neutrophil count to greater than 500/mm^3 for > 3 days without filgrastim (G-CSF) support and within 40 days of transplant (i.e. complete blood counts [CBCs] obtained 3 or more days apart while off of G-CSF must demonstrate an absolute neutrophil count > 500/mm^3); if absolute neutropenia is not achieved due to a non-myeloablative transplant, the patient can be enrolled on day +21 to +40